Benzylboronic acid
CAS: 4463-42-7
Ref. 3D-FB146781
| 1g | A consultar | ||
| 2g | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
- boronic acid, B-(phenylmethyl)-
- Phenylmethylboronic acid
Benzylboronic acid is a drug target for the treatment of type 2 diabetes. It is used to inhibit glucose monitoring in the body and has been shown to be effective in treating type 2 diabetes by inhibiting gluconeogenesis. Benzylboronic acid has been shown to have an inhibitory effect on toll-like receptor 4 (TLR4) and TLR2, which are involved in the inflammatory response, as well as TLR9, which is involved in the activation of B cells. Benzylboronic acid also inhibits bortezomib, an anti-cancer drug that can cause bone marrow suppression. Benzylboronic acid binds to pyridinium derivatives and esters with nucleophilic groups and forms a covalent bond with them through cross-coupling reactions. This process leads to the formation of a new compound that contains a carbonyl group.
Propiedades químicas
Consulta técnica sobre: 3D-FB146781 Benzylboronic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
